Polydimethylsiloxane for Cutting-Edge Research

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery

products and services, has announced an expanded portfolio of Polydimethylsiloxane
(PDMS) products, empowering researchers with versatile and biocompatible tools for
groundbreaking discoveries.

Polydimethylsiloxane is an elastomeric polymer with interesting properties for

biomedical applications, including non-physiological reactivity, excellent resistance to
biodegradation, biocompatibility, chemical stability, gas permeability, good
mechanical properties, excellent optical transparency, and easy replication molding.
Based on these properties, PDMS has been used in a wide range of applications such
as micropumps, catheter surfaces, dressings and bandages, microvalves, optical
systems, in vitro disease studies, implants, microfluidics, and photonics.

In addition, PDMS is the most widely used material for the manufacture of
microfluidic devices, which are an important technology for the development of
systems for drug delivery, DNA sequencing, clinical diagnostics, point-of-care testing,
and chemical synthesis. The materials used in these systems should be biocompatible,
optically transparent, rapid to prototype and low cost to manufacture, characteristics
of PDMS.

In the pharmaceutical field, PDMS derivatives have been widely used as coatings for
controlled drug delivery systems. The main advantages of these materials are the
ease of tuning the desired drug release pattern, improved film formation and storage
stability. Recognizing its immense potential, CD Bioparticles has significantly
broadened its PDMS offerings to cater to the evolving needs of researchers, including
PDMS Grafted Triethoxysilane, Si-PSSNa, Butyl-PDMS-Triethoxysilane, and
Cyclocarbonate-PDMS-Cyclocarbonate.

CD Bioparticles offers various Biopolymers & Synthetic Polymers for customers

worldwide. CD Bioparticles is committed to easing the burden on its customers by
reducing cumbersome chemical synthesis, formulation and purification, improving
drug loading efficiency and yield of drug delivery materials, and helping customers
track and image the distribution of polymer-based (nano)materials to avoid strong
immunoreactivity or xenobiotic reactions to the materials.

CD Bioparticles can provide customers with a wide range of functional

groups/targeting ligands/tags covering polymers for loading, modification, specific
targeting, tracking and detection, as well as functional groups in different densities or
different chemical geometries to fabricate biomaterials with controllable
functionality and other physical/chemical properties (e.g. mechanical properties of
cross-linking agents), helping customers to improve the biocompatibility, activity and
functionality of polymers that allow for controlled delivery profiles of drug delivery
vehicles.

Beyond the diverse product range, CD Bioparticles also provides exceptional

customer support, offering expert guidance and technical assistance to researchers
navigating the intricacies of PDMS utilization.

With its expanded PDMS portfolio and unwavering commitment to scientific

advancement, CD Bioparticles strives to provide its customers with the most accurate
and reliable tools for drug delivery. For more information on the new PDMS, please
visit https://www.cd-bioparticles.net/polydimethylsiloxane.

About CD Bioparticles

CD Bioparticles is an established drug delivery company that provides customized

solutions for developing and manufacturing novel biocompatible drug delivery
systems. It specializes in various formulation and drug delivery technologies, from
conventional liposomes and PEGylated liposomes to polymer microspheres and
nanoparticles for drug delivery. The company also provides contract research
services for drug delivery formulation, formulation feasibility study, process
development and scale-up, as well as analytical and non-clinical research services.